Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
This report aims to provide a comprehensive presentation of the global market for Repurposed Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Repurposed Drugs. This report contains market size and forecasts of Repurposed Drugs in global, including the following market information:
Global Repurposed Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Repurposed Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Generic Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Repurposed Drugs include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group and Glenmark, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Repurposed Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Repurposed Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Repurposed Drugs Market Segment Percentages, by Type, 2022 (%)
Generic Drugs
Clinical Trial Failed Drugs
Global Repurposed Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Repurposed Drugs Market Segment Percentages, by Application, 2022 (%)
Cardiovascular Diseases
Mental Illness
Cancer
Other
Global Repurposed Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Repurposed Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Repurposed Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Repurposed Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Repurposed Drugs, market overview.
Chapter 2: Global Repurposed Drugs market size in revenue.
Chapter 3: Detailed analysis of Repurposed Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Repurposed Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Repurposed Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Repurposed Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Repurposed Drugs Overall Market Size
2.1 Global Repurposed Drugs Market Size: 2022 VS 2030
2.2 Global Repurposed Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Repurposed Drugs Players in Global Market
3.2 Top Global Repurposed Drugs Companies Ranked by Revenue
3.3 Global Repurposed Drugs Revenue by Companies
3.4 Top 3 and Top 5 Repurposed Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Repurposed Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Repurposed Drugs Players in Global Market
3.6.1 List of Global Tier 1 Repurposed Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Repurposed Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Repurposed Drugs Market Size Markets, 2022 & 2030
4.1.2 Generic Drugs
4.1.3 Clinical Trial Failed Drugs
4.2 By Type - Global Repurposed Drugs Revenue & Forecasts
4.2.1 By Type - Global Repurposed Drugs Revenue, 2018-2023
4.2.2 By Type - Global Repurposed Drugs Revenue, 2024-2030
4.2.3 By Type - Global Repurposed Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Repurposed Drugs Market Size, 2022 & 2030
5.1.2 Cardiovascular Diseases
5.1.3 Mental Illness
5.1.4 Cancer
5.1.5 Other
5.2 By Application - Global Repurposed Drugs Revenue & Forecasts
5.2.1 By Application - Global Repurposed Drugs Revenue, 2018-2023
5.2.2 By Application - Global Repurposed Drugs Revenue, 2024-2030
5.2.3 By Application - Global Repurposed Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Repurposed Drugs Market Size, 2022 & 2030
6.2 By Region - Global Repurposed Drugs Revenue & Forecasts
6.2.1 By Region - Global Repurposed Drugs Revenue, 2018-2023
6.2.2 By Region - Global Repurposed Drugs Revenue, 2024-2030
6.2.3 By Region - Global Repurposed Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Repurposed Drugs Revenue, 2018-2030
6.3.2 US Repurposed Drugs Market Size, 2018-2030
6.3.3 Canada Repurposed Drugs Market Size, 2018-2030
6.3.4 Mexico Repurposed Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Repurposed Drugs Revenue, 2018-2030
6.4.2 Germany Repurposed Drugs Market Size, 2018-2030
6.4.3 France Repurposed Drugs Market Size, 2018-2030
6.4.4 U.K. Repurposed Drugs Market Size, 2018-2030
6.4.5 Italy Repurposed Drugs Market Size, 2018-2030
6.4.6 Russia Repurposed Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Repurposed Drugs Market Size, 2018-2030
6.4.8 Benelux Repurposed Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Repurposed Drugs Revenue, 2018-2030
6.5.2 China Repurposed Drugs Market Size, 2018-2030
6.5.3 Japan Repurposed Drugs Market Size, 2018-2030
6.5.4 South Korea Repurposed Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Repurposed Drugs Market Size, 2018-2030
6.5.6 India Repurposed Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Repurposed Drugs Revenue, 2018-2030
6.6.2 Brazil Repurposed Drugs Market Size, 2018-2030
6.6.3 Argentina Repurposed Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Repurposed Drugs Revenue, 2018-2030
6.7.2 Turkey Repurposed Drugs Market Size, 2018-2030
6.7.3 Israel Repurposed Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Repurposed Drugs Market Size, 2018-2030
6.7.5 UAE Repurposed Drugs Market Size, 2018-2030
7 Repurposed Drugs Companies Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Repurposed Drugs Major Product Offerings
7.1.4 Teva Repurposed Drugs Revenue in Global Market (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Repurposed Drugs Major Product Offerings
7.2.4 Novartis Repurposed Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Repurposed Drugs Major Product Offerings
7.3.4 Mylan Repurposed Drugs Revenue in Global Market (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Repurposed Drugs Major Product Offerings
7.4.4 Johnson & Johnson Repurposed Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Repurposed Drugs Major Product Offerings
7.5.4 Pfizer Repurposed Drugs Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Bausch Health
7.6.1 Bausch Health Company Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Repurposed Drugs Major Product Offerings
7.6.4 Bausch Health Repurposed Drugs Revenue in Global Market (2018-2023)
7.6.5 Bausch Health Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Repurposed Drugs Major Product Offerings
7.7.4 GSK Repurposed Drugs Revenue in Global Market (2018-2023)
7.7.5 GSK Key News & Latest Developments
7.8 ChemRar Group
7.8.1 ChemRar Group Company Summary
7.8.2 ChemRar Group Business Overview
7.8.3 ChemRar Group Repurposed Drugs Major Product Offerings
7.8.4 ChemRar Group Repurposed Drugs Revenue in Global Market (2018-2023)
7.8.5 ChemRar Group Key News & Latest Developments
7.9 Glenmark
7.9.1 Glenmark Company Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Repurposed Drugs Major Product Offerings
7.9.4 Glenmark Repurposed Drugs Revenue in Global Market (2018-2023)
7.9.5 Glenmark Key News & Latest Developments
7.10 Fujifilm
7.10.1 Fujifilm Company Summary
7.10.2 Fujifilm Business Overview
7.10.3 Fujifilm Repurposed Drugs Major Product Offerings
7.10.4 Fujifilm Repurposed Drugs Revenue in Global Market (2018-2023)
7.10.5 Fujifilm Key News & Latest Developments
7.11 Dr. Reddy
7.11.1 Dr. Reddy Company Summary
7.11.2 Dr. Reddy Business Overview
7.11.3 Dr. Reddy Repurposed Drugs Major Product Offerings
7.11.4 Dr. Reddy Repurposed Drugs Revenue in Global Market (2018-2023)
7.11.5 Dr. Reddy Key News & Latest Developments
7.12 R-Pharma
7.12.1 R-Pharma Company Summary
7.12.2 R-Pharma Business Overview
7.12.3 R-Pharma Repurposed Drugs Major Product Offerings
7.12.4 R-Pharma Repurposed Drugs Revenue in Global Market (2018-2023)
7.12.5 R-Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Repurposed Drugs Market Opportunities & Trends in Global Market
Table 2. Repurposed Drugs Market Drivers in Global Market
Table 3. Repurposed Drugs Market Restraints in Global Market
Table 4. Key Players of Repurposed Drugs in Global Market
Table 5. Top Repurposed Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Repurposed Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Repurposed Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Repurposed Drugs Product Type
Table 9. List of Global Tier 1 Repurposed Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Repurposed Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Repurposed Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Repurposed Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Repurposed Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Repurposed Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Repurposed Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Repurposed Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Repurposed Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Repurposed Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Repurposed Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Repurposed Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Repurposed Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Repurposed Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Repurposed Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Repurposed Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Repurposed Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Repurposed Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Repurposed Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Repurposed Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Repurposed Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Teva Company Summary
Table 31. Teva Repurposed Drugs Product Offerings
Table 32. Teva Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Teva Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Repurposed Drugs Product Offerings
Table 36. Novartis Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Mylan Company Summary
Table 39. Mylan Repurposed Drugs Product Offerings
Table 40. Mylan Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Mylan Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Repurposed Drugs Product Offerings
Table 44. Johnson & Johnson Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Repurposed Drugs Product Offerings
Table 48. Pfizer Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Bausch Health Company Summary
Table 51. Bausch Health Repurposed Drugs Product Offerings
Table 52. Bausch Health Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Bausch Health Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Repurposed Drugs Product Offerings
Table 56. GSK Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. ChemRar Group Company Summary
Table 59. ChemRar Group Repurposed Drugs Product Offerings
Table 60. ChemRar Group Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. ChemRar Group Key News & Latest Developments
Table 62. Glenmark Company Summary
Table 63. Glenmark Repurposed Drugs Product Offerings
Table 64. Glenmark Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Glenmark Key News & Latest Developments
Table 66. Fujifilm Company Summary
Table 67. Fujifilm Repurposed Drugs Product Offerings
Table 68. Fujifilm Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Fujifilm Key News & Latest Developments
Table 70. Dr. Reddy Company Summary
Table 71. Dr. Reddy Repurposed Drugs Product Offerings
Table 72. Dr. Reddy Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Dr. Reddy Key News & Latest Developments
Table 74. R-Pharma Company Summary
Table 75. R-Pharma Repurposed Drugs Product Offerings
Table 76. R-Pharma Repurposed Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. R-Pharma Key News & Latest Developments
List of Figures
Figure 1. Repurposed Drugs Segment by Type in 2022
Figure 2. Repurposed Drugs Segment by Application in 2022
Figure 3. Global Repurposed Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Repurposed Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Repurposed Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Repurposed Drugs Revenue in 2022
Figure 8. By Type - Global Repurposed Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Repurposed Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Repurposed Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Repurposed Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Repurposed Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Repurposed Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Repurposed Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Repurposed Drugs Revenue Market Share, 2018-2030
Figure 16. US Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Repurposed Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Repurposed Drugs Revenue Market Share, 2018-2030
Figure 28. China Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Repurposed Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Repurposed Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Repurposed Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Teva Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bausch Health Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GSK Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ChemRar Group Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Glenmark Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Fujifilm Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Dr. Reddy Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. R-Pharma Repurposed Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
